Cumberland Pharmaceuticals Inc
CPIX· Nasdaq
Cumberland Pharmaceuticals Inc
- Last sale
- Oct 2, 2026 · -0.67%
- Market cap
- $110.73M
- 14.98M shares
- Filings
- 1,006
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $44,521,431 | reported | |
| FY 2024 | 2024-12-31 | $37,867,945 | reported | |
| FY 2023 | 2023-12-31 | $39,552,507 | reported | |
| FY 2022 | 2022-12-31 | $42,010,949 revised | reported | |
| FY 2021 | 2021-12-31 | $35,045,259 | reported | |
| FY 2020 | 2020-12-31 | $35,840,673 | reported | |
| FY 2019 | 2019-12-31 | $32,407,845 revised | reported | |
| FY 2018 | 2018-12-31 | $28,803,961 revised | reported | |
| FY 2017 | 2017-12-31 | $40,376,563 revised | reported | |
| FY 2016 | 2016-12-31 | $32,478,185 revised | reported | |
| FY 2015 | 2015-12-31 | $900,000 | reported | |
| FY 2014 | 2014-12-31 | $600,000 | reported |
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
